The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

Introduction: Obesity is compounded by a neurobiology that is resistant to weight loss.
Therefore, the development of pharmacotherapies to address the pathology underlying the …

Pharmacotherapy has a role in obesity management when combined with diet, physical
activity, and behavior modification. Currently available therapies are safe when used …

Public health initiatives focused on obesity prevention and lifestyle intervention programmes
for patients with obesity have struggled to contain the obesity epidemic to date. In recent …

The ideal anti-obesity drug would produce sustained weight loss with minimal side effects.
The mechanisms that regulate energy balance have substantial built-in redundancy, overlap …

Introduction: When used prudently and in combination with lifestyle modification,
pharmacotherapy has an important role in the management of obesity. Areas covered: This …

Introduction: Obesity is a worldwide pandemic. Obesity-related health and economic costs
are staggering. Existing strategies to combat obesity through lifestyle improvements and …

Abstract Purpose of Review Obesity is a global health crisis with detrimental effects on all
organ systems leading to worsening disease state and rising costs of care. Persons with …

650 millions of adults are obese worldwide-in the US alone, forty percent of the adults are
obese. Although the obesity pandemic is constantly expanding at very high costs for health …

Treating obesity is crucial as it will ultimately result in the prevention of many related chronic
diseases and will decrease morbidity and mortality. Weight loss medications are a valuable …